| pubmed-article:21298051 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21298051 | lifeskim:mentions | umls-concept:C0019704 | lld:lifeskim |
| pubmed-article:21298051 | lifeskim:mentions | umls-concept:C0037173 | lld:lifeskim |
| pubmed-article:21298051 | lifeskim:mentions | umls-concept:C0040223 | lld:lifeskim |
| pubmed-article:21298051 | lifeskim:mentions | umls-concept:C1332714 | lld:lifeskim |
| pubmed-article:21298051 | lifeskim:mentions | umls-concept:C0205217 | lld:lifeskim |
| pubmed-article:21298051 | lifeskim:mentions | umls-concept:C1521828 | lld:lifeskim |
| pubmed-article:21298051 | lifeskim:mentions | umls-concept:C1963724 | lld:lifeskim |
| pubmed-article:21298051 | lifeskim:mentions | umls-concept:C0449560 | lld:lifeskim |
| pubmed-article:21298051 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:21298051 | pubmed:dateCreated | 2011-2-7 | lld:pubmed |
| pubmed-article:21298051 | pubmed:abstractText | It remains controversial as to whether HIV-1 subtypes influence disease progression. Singapore offers a unique opportunity to address this issue due to the presence of co-circulating subtypes. We compared subtype CRF01_AE and non-CRF01_AE infected patients, with regards to estimated annual rate of CD4+ T-cell loss and time from estimated data of seroconversion (EDS) to antiretroviral therapy (ART). | lld:pubmed |
| pubmed-article:21298051 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21298051 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21298051 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21298051 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21298051 | pubmed:issn | 1932-6203 | lld:pubmed |
| pubmed-article:21298051 | pubmed:author | pubmed-author:JooFF | lld:pubmed |
| pubmed-article:21298051 | pubmed:author | pubmed-author:LeeCheng... | lld:pubmed |
| pubmed-article:21298051 | pubmed:author | pubmed-author:QuinnThomas... | lld:pubmed |
| pubmed-article:21298051 | pubmed:author | pubmed-author:LeoYee SinYS | lld:pubmed |
| pubmed-article:21298051 | pubmed:author | pubmed-author:SunYong... | lld:pubmed |
| pubmed-article:21298051 | pubmed:author | pubmed-author:LaeyendeckerO... | lld:pubmed |
| pubmed-article:21298051 | pubmed:author | pubmed-author:NgOon TekOT | lld:pubmed |
| pubmed-article:21298051 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21298051 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:21298051 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21298051 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21298051 | pubmed:pagination | e15738 | lld:pubmed |
| pubmed-article:21298051 | pubmed:dateRevised | 2011-10-7 | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:meshHeading | pubmed-meshheading:21298051... | lld:pubmed |
| pubmed-article:21298051 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21298051 | pubmed:articleTitle | Increased rate of CD4+ T-cell decline and faster time to antiretroviral therapy in HIV-1 subtype CRF01_AE infected seroconverters in Singapore. | lld:pubmed |
| pubmed-article:21298051 | pubmed:affiliation | Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore Maryland, United States of America. oong@jhsph.edu | lld:pubmed |
| pubmed-article:21298051 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21298051 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21298051 | pubmed:publicationType | Research Support, N.I.H., Intramural | lld:pubmed |
